About Vacuolar protein-sorting-associated protein 36
Vacuolar protein-sorting-associated protein 36 (VPS36) is a protein
from Homo sapiens identified by UniProt accession
Q86VN1, 386 residues long.
MolForge cross-references it against 0 known binders and
52 disease associations.
Target properties
| Protein name | Vacuolar protein-sorting-associated protein 36 |
| UniProt accession | Q86VN1 |
| Gene | VPS36 |
| Organism | Homo sapiens |
| Length | 386 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (52)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.53
- viral disease · score 0.46
- age-related macular degeneration · score 0.17
- retinitis pigmentosa · score 0.11
- disease of genitourinary system · score 0.09
- X-linked retinal dysplasia · score 0.08
- Progressive cone dystrophy · score 0.07
- Familial exudative vitreoretinopathy · score 0.07
- severe early-childhood-onset retinal dystrophy · score 0.06
- choroidal dystrophy, central areolar, 1 · score 0.06
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q86VN1-F1 | alphafold | PREDICTED | 82.77 | — |
Amino-acid sequence (386 residues)
MDRFVWTSGL LEINETLVIQ QRGVRIYDGE EKIKFDAGTL LLSTHRLIWR DQKNHECCMA ILLSQIVFIE EQAAGIGKSA KIVVHLHPAP PNKEPGPFQS SKNSYIKLSF KEHGQIEFYR RLSEEMTQRR WENMPVSQSL QTNRGPQPGR IRAVGIVGIE RKLEEKRKET DKNISEAFED LSKLMIKAKE MVELSKSIAN KIKDKQGDIT EDETIRFKSY LLSMGIANPV TRETYGSGTQ YHMQLAKQLA GILQVPLEER GGIMSLTEVY CLVNRARGME LLSPEDLVNA CKMLEALKLP LRLRVFDSGV MVIELQSHKE EEMVASALET VSEKGSLTSE EFAKLVGMSV LLAKERLLLA EKMGHLCRDD SVEGLRFYPN LFMTQS
Explore Vacuolar protein-sorting-associated protein 36 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets